Stock Events

Stock Events

Bristol-Myers Squibb 

$66.82
8978
-$1.27-1.87% Friday 20:00
+$0.18+0.27%Friday 23:56After hours

Statistics

Day High
67.72
Day Low
66.58
52W High
68.64
52W Low
42.52
Volume
4,585,275
Avg. Volume
11,469,311
Mkt Cap
136.49B
P/E Ratio
16.13
Dividend Yield
3.77%
Dividend
2.52

Upcoming

Dividends

3.77%Dividend Yield
Aug 26
$0.63
May 26
$0.63
Feb 26
$0.63
Nov 25
$0.62
Aug 25
$0.62
10Y Growth
5.21%
5Y Growth
5.51%
3Y Growth
3.71%
1Y Growth
2.03%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.09
1.41
1.72
2.04
Expected EPS
1.723733
Actual EPS
N/A

Financials

14.64%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
48.19BRevenue
7.05BNet Income

Analyst Ratings

67.70Average Price Target
The highest estimate is 75.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMY. It's not an investment recommendation.
Realty Income
2356
O
Coca-Cola
1990
KO
Apple
1982
AAPL
Johnson & Johnson
1948
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap366B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap233.78B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Show more...
CEO
Christopher S. Boerner
Employees
32500
Country
United States
ISIN
US1101221083
WKN
000850501

Listings

STU
DE
BRM.STU
XETRA
DE
BRM.XETRA
BA
AR
BMY.BA
SA
BR
BMYB34.SA

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?▼
The current price of BMY is $66.82 USD — it has decreased by -1.87% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bristol-Myers Squibb stocks are traded under the ticker BMY.
Is Bristol-Myers Squibb stock price growing?▼
BMY stock has risen by +0.36% compared to the previous week, the month change is a +5.01% rise, over the last year Bristol-Myers Squibb has showed a +41.75% increase.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 136.49B
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on October 29, 2026.
What were Bristol-Myers Squibb earnings last quarter?▼
BMY earnings for the last quarter are 2.04 USD per share, whereas the estimation was 1.6 USD resulting in a +27.73% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 48.19B USD.
What is Bristol-Myers Squibb net income for the last year?▼
BMY net income for the last year is 7.05B USD.
Does Bristol-Myers Squibb pay dividends?▼
Yes, BMY dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (FWD)% is 3.77%.
How many employees does Bristol-Myers Squibb have?▼
As of September 05, 2026, the company has 32,500 employees.
In which sector is Bristol-Myers Squibb located?▼
Bristol-Myers Squibb operates in the Health & Wellness sector.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.
Where is Bristol-Myers Squibb headquartered?▼
Bristol-Myers Squibb is headquartered in PRINCETON, United States.